The BIO Protocol is the leading protocol of the DeSci (Decentralized Science) trend, aiming to promote biotechnology development and improve human life. Recently, BIO was launched as the 63rd project on Binance's launchpool platform and will be listed on January 3, 2025.
1. What is the BIO protocol?
The BIO Protocol is designed as a governance and liquidity protocol specifically for the decentralized science (DeSci) field. Its mission is to facilitate biotechnology development by connecting and empowering global patient communities, scientists, and biotechnology professionals, enabling them to co-fund, build, and jointly own crypto and transparently managed biotechnology projects and intellectual property (IP).
The team behind the BIO Protocol includes the creators of Molecule (a platform for tokenizing early biomedical research) and VitaDAO (the largest decentralized community focused on longevity science). Building on these successes, the BIO Protocol aims to establish a blockchain-based scientific economy through decentralized funding, incentive mechanisms, and project liquidity.
On December 23, 2024, Binance officially launched the BIO Protocol, becoming the 63rd project in Binance's new token pool. Binance plans to list BIO tokens on January 3, 2025, at 10:00 AM (UTC).
Decentralized Science (DeSci) is a concept that combines science with blockchain technology, aiming to create a transparent, fair, and decentralized research ecosystem. DeSci leverages blockchain to facilitate open and transparent research funding, intellectual property management, and content publishing.
This model transforms scientific research from a 'black box' into an open space that encourages collaboration and innovation through collective intelligence. Since the beginning of 2023, DeSci has gained significant attention, especially after receiving investment from Binance Labs and endorsement from Binance founder CZ.
2. Key products of the BIO Protocol
The BIO Protocol has launched three strategic products: BIO Protocol (core infrastructure), BIO Launchpad (funding platform), BioDAO Incubator (project incubation program).
The BIO protocol is the core infrastructure of the ecosystem, supporting the on-chain economy of bioDAO (decentralized scientific research community).
Key features include:
IP Market: A platform for buying and trading intellectual property assets.
Liquidity System: Facilitates efficient capital flow.
IP Management: Tools for ownership, licensing, and trading of IP assets.
How BioDAO operates:
BioDAO raises funds by issuing tokens, which are then used to support biotechnology projects.
These projects create shared IP ownership among BioDAO members, leveraging Molecule's on-chain IP framework for IP management, licensing, and trading.
IP usage and related product revenues flow back to the BioDAO treasury for reinvestment into next-generation R&D, advancing the organization's mission.
Advantages of BioDAO compared to traditional research models:
Capital efficiency: Shared resources reduce innovation costs.
Flexible workforce: Experts can work part-time.
Shared intellectual property: Encouraging contributions through intellectual property benefits.
Open access: Removing barriers to funding and decision-making.
Diversified portfolio: Simultaneous projects can reduce risks.
2.2. BIO Launchpad
BIO Launchpad is a fundraising platform that connects investors with biotechnology projects, allowing BioDAO to raise funds for research activities.
Operating model:
Investors: Invest funds and specify the maximum price they are willing to pay within a set timeframe.
Projects: After the auction ends, investors may receive tokens if selected.
Goals:
Empower the BIO community to choose which DAOs to support and launch.
Provide initial funding and deep liquidity after project launch.
Three operational phases:
Governance: Assess and decide which projects qualify for the BIO protocol.
Acceleration: Mobilize funds from the community.
Separation: Launch projects on the public market with liquidity support.
2.3. BioDAO Incubator
The BioDAO incubator nurtures potential biotechnology projects that integrate blockchain technology with decentralized scientific research.
Funding support: Seed capital for project development.
Expert guidance: Guidance from biotechnology and blockchain experts.
Technical resources: Tools for effectively building and operating BioDAO.
Goals:
Advancing decentralized science.
Building public research infrastructure.
Harnessing the potential of Web3, IP-NFT, and token economics to drive innovation.
The BIO Protocol has a complete ecosystem and a clear strategy to support biotechnology projects while laying the foundation for a modern, transparent, and community-driven research system.
3. BIO Ecosystem
The BIO Protocol's ecosystem features outstanding projects focused on advanced scientific research, providing groundbreaking solutions for humanity:
VitaDAO: Pioneer of longevity science.
AthenaDAO: Focused on women's health.
PsyDAO: Integrating science and art to explore psychiatry.
ValleyDAO: Developing biotechnology solutions for environmental issues.
HairDAO: Providing solutions for hair loss.
CryoDAO: Innovations in cryopreservation.
CerebrumDAO: Research on brain health and prevention of neurodegenerative diseases.
Curetopia: Developing treatments for rare diseases.
Long COVID Labs: Addressing long COVID syndrome.
Quantum Biology DAO: Applying advanced electron microscopy to biological research.
4. Team
The BIO Protocol has an experienced professional team combining expertise in blockchain and biotechnology:
Paul Kohlhaas – Founder and CEO: Paul is a pioneer in DeSci, the CEO of Molecule, and a co-founder of VitaDAO. Before founding the BIO Protocol, he held significant positions at ConsenSys and contributed to blockchain solutions for the Swiss government.
Clemens Ortlepp – Co-founder and Chief Product Officer: As the Chief Product Officer of the BIO Protocol and co-founder of MTX Studio, Clemens has extensive experience in decentralized technology. Previously, he served as the Product Director at Molecule.
5. Investors
On November 8, 2024, the BIO Protocol received strategic investment from Binance Labs, a leading blockchain investment fund. Although the investment amount was not disclosed, this recognition highlights Binance's confidence in the potential of the BIO Protocol.
6. Roadmap
Q4 2024:
Launch testnet.
Integrate vBIO into the Solana ecosystem.
Q1 2025:
BIO Protocol Launchpad officially launched.
Enable BIO token trading.
Support liquidity pairs on the BIO platform.
Q2 2025:
Hold the second community auction.
Release BIO research agency.
Q3 2025:
Introduce new BioDAO.
7. Similar projects
The BIO Protocol is currently a leading project in the DeSci field.
8. Overview of BIO tokens
8.1. Basic Information
Token Name: BIO
Token Symbol: BIO
Blockchain: Ethereum
Smart Contract: 0xcb1592591996765Ec0eFc1f92599A19767ee5ffA
Listing Date: January 3, 2025
Total Supply: 3,320,000,000 BIO
Circulating Supply: 1,296,529,168 BIO (39.05% of total supply)
8.2. BIO Token Distribution
The distribution of BIO tokens is as follows:
Community (56%)
Community Auction (20%): 50% will be used to provide liquidity, and the remaining 50% will be gradually unlocked over 1 year.
Community Airdrop (6%): Rewards for BioDAO token holders and early contributors to the BIO protocol. These tokens are locked for 1 year and then unlocked over 6 years.
Ecosystem Incentives (25%): No lock-up mechanism.
Molecule Ecosystem Fund (5%): Gradually unlocked over 4 years.
Investors (13.6%)
Tokens locked for 1 year and then unlocked over 4 years.
Core Contributors (21.2%)
Tokens locked for 1 year and then unlocked over 6 years.
Advisors (4.2%)
Tokens locked for 1 year and then unlocked over 6 years.
Molecule (5%)
Gradually unlocked over 4 years.
8.3. BIO Token Unlocking Plan
The total supply of BIO tokens is expected to be fully unlocked within 7 years from the official listing date.
8.4. Applications of the BIO Token
Governance and decision-making
BIO token holders can participate in the management of the BIO protocol ecosystem.
Contribute to decision-making regarding the selection, management, and operational rules of BioDAO.
Financial management
Vote on fund allocation, token issuance adjustments, and community incentive programs.
Ecosystem incentives
Enjoy discounts and benefits when using health-related products and services from BioDAOs within the network.
8.5. Where to buy BIO tokens
Starting from January 3, 2025, investors can obtain BIO on major exchanges such as Anan.
9. Potential of the BIO protocol
9.1. Advantages
Pioneering DeSci (Decentralized Science)
A promising field combining science, biotechnology, and blockchain.
Practical products
Core products such as BIO Protocol (infrastructure layer), BIO Launchpad (funding platform), and BioDAO Incubator (project accelerator) have high practical value.
Robust ecosystem
Includes renowned BioDAOs like VitaDAO, AthenaDAO, and ValleyDAO, covering various fields from women's health research and longevity to environmental protection.
Experienced team and strong backing
Led by professionals with deep expertise in blockchain and biotechnology. Supported by Binance and Binance Labs.
9.2. Risks and challenges
New field
DeSci is an emerging field that requires time and effort to gain attention in the traditional scientific community.
Potential competition
Future entrants into this field may undermine the advantages of the BIO Protocol.
Initial large supply
The massive initial supply (3,320,000,000 BIO) and over 50% community allocation may raise concerns about sell-off pressure.
Adoption dependency
Success largely depends on the endorsement of researchers, the scientific community, and investors.
10. Conclusion
The BIO Protocol is a promising project with the potential to lead the DeSci industry, thanks to its innovative approach, outstanding team, and support from key investors. However, it faces significant challenges, particularly in driving adoption and managing token inflation pressure.
For investors, this project is worth considering for medium to long-term investment, especially as the DeSci field continues to expand and the BIO Protocol maintains its pioneering status.
In 2025, DeSci will surely rise!
